Found: 23
Select item for more details and to access through your institution.
Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision? Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1300, doi. 10.1111/apt.17976
- By:
- Publication type:
- Article
Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision?
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1167, doi. 10.1111/apt.17581
- Publication type:
- Article
Editorial: Novel insights into the prognostic relevance of high‐dose PPI treatment in patients with cirrhosis.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Letter: Bif195 for aspirin‐induced gastric mucosal damage – More to do in further research. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1306, doi. 10.1111/apt.18002
- By:
- Publication type:
- Article
Editorial: Crystalising the burden of steatotic liver disease—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Editorial: Crystalising the burden of steatotic liver disease.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Letter: Bif195 for aspirin‐induced gastric mucosal damage—More to do in further research.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1304, doi. 10.1111/apt.17984
- By:
- Publication type:
- Article
Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find. Author's reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1302, doi. 10.1111/apt.17982
- By:
- Publication type:
- Article
Editorial: Adequate protein intake is more crucial than the profile of amino acids intake for sarcopenia prevention during the earlier stages of liver cirrhosis.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Review article: Recent advances in ascites and acute kidney injury management in cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1196, doi. 10.1111/apt.17972
- By:
- Publication type:
- Article
Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1183, doi. 10.1111/apt.17967
- By:
- Publication type:
- Article
Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1271, doi. 10.1111/apt.17958
- By:
- Publication type:
- Article
Review article: Telecare in gastroenterology—Within the COVID‐19 pandemic and beyond.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1170, doi. 10.1111/apt.17956
- By:
- Publication type:
- Article
Editorial: Are glucagon‐like peptide‐1 receptor agonists the functional cure for patients with metabolic dysfunction‐associated cirrhosis?
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Development and validation of a brain fog scale for coeliac disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1260, doi. 10.1111/apt.17942
- By:
- Publication type:
- Article
Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated steatotic liver disease: A randomised, controlled proof‐of‐concept study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1212, doi. 10.1111/apt.17941
- By:
- Publication type:
- Article
Editorial: Terlipressin and MDRO colonisation in cirrhosis—Is there a causal link?
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Effectiveness and safety of a third‐line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1248, doi. 10.1111/apt.17938
- By:
- Publication type:
- Article
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1236, doi. 10.1111/apt.17936
- By:
- Publication type:
- Article
CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1223, doi. 10.1111/apt.17933
- By:
- Publication type:
- Article